 reuters    two key u s  congressional committee members on friday called for an investigation into whether mylan nv  under fire for raising the price of its epipen device  overcharged the government s low income healthcare program for the allergy treatment  in a letter to the secretary of the department of health and human services  senator ron wyden and representative frank pallone  both democrats  seek clarification of whether epipen was classified as a generic   non innovator  drug  or a brand name drug by the medicaid program  under current law  branded drugs  and generic drugs available from a single source  are required to pay a rebate amount of at least   percent of the average manufacturer price  generic drugs are subject to a much lower  percent rebate  mylan  in an emailed statement  said it has complied with all laws and regulations regarding medicaid rebates  and intends to file with regulators  by next april as required under new guidelines  for epipen to be classified as a  non innovator  product  the device jabs a dose of the drug epinephrine into the thigh to counter dangerous allergic reactions such as to peanuts  food allergies and bee stings   mylan  whose tax address is in the netherlands but which has corporate headquarters in canonsburg  pennsylvania  has raised the u s  price of epipen from less than   when it acquired the product in  to more than    amid an outcry by parents  consumer groups and u s  politicians  the company said on monday it will soon launch the first generic version of the device for    half the list price of its branded product   wyden  ranking member of the senate finance committee  and pallone  ranking member of the house energy   commerce committee  said in the letter on friday   it has recently come to our attention that mylan has classified epipen as a generic drug  under the medicaid rebate program  even though it is considered a new drug by the food and drug administration  shares of mylan  which fell   percent to close at    on friday  have dropped  percent since mid august  